, Tracking Stock Market Picks
Enter Symbol:
Cleveland Biolabs, Inc. (CBLI) [hlAlert]

down 47.76 %

Cleveland Biolabs, Inc. (CBLI) rated Outperform with price target $10 by Wedbush

Posted on: Wednesday,  Feb 2, 2011  8:25 AM ET by Wedbush

Wedbush rated Outperform Cleveland Biolabs, Inc. (NASDAQ: CBLI) on 02/02/2011, when the stock price was $7.16. Since
then, Cleveland Biolabs, Inc. has lost 47.77% as of 08/27/2015's recent price of $3.74.
If you would have followed this Wedbush 's recommendation on CBLI, you would have lost 47.76% of your investment in 1667 days.

Cleveland BioLabs, Inc. (CBLI) is a development-stage biotechnology company. The Company is focused on developing cancer treatment, tissue protection and biodefense drugs. The Company?s pipeline includes products from two primary families of compounds: protectans and curaxins. CBLI is developing protectans as drug candidates that protect healthy tissues from acute stresses such as radiation, chemotherapy and ischemia (pathologies that develop as a result of blocking blood flow to a part of the body). Curaxins are being developed as anticancer agents that could act as mono-therapy drugs or in combination with other existing anticancer therapies.

Wedbush is Headquartered in Los Angeles, California with over 90 offices and more than 125 correspondent offices, our commitment to providing relentless, customized service is the foundation of our consistent growth. We deliver superior investment ideas and products through exceptional customer care, financial security, continuity and advanced technology.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/2/2011 8:25 AM Buy
7.16 10.00
as of 12/30/2011
1 Week up  1.06 %
1 Month down  -2.38 %
3 Months up  13.04 %
1 YTD down  -60.05 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy